Mandate

Vinge advises Hexatronic in connection with the acquisition of Proximion

August 20, 2014

Vinge has advised Hexatronic Scandinavia AB (publ), listed on NASDAQ OMX First North, in connection with the acquisition of the shares in Proximion AB. Proximion manufactures, develops and sells optical modules and sub-systems based on Fiber Bragg Grating (FBG) technology which, among other things, facilitates long-distance transfer of data in fiber networks. The purchase price for the shares amounts to SEK 55 000 000 as well as results based supplementary purchase price in the maximum amount of SEK 8 000 000. The purchase price will be paid in cash and through newly issued shares in Hexatronic.

Vinge’s team consisted of responsible partner Anders Strid together with associates Anna Seisling and Patrik Gargolinski.

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised EQT managed Scaleup Europe Fund on its investment in Tandem Health

Vinge has advised EQT managed Scaleup Europe Fund as lead investor in Tandem Health's USD 100 million Series B investment round, with participation from existing investors Kinnevik, Northzone, Amino Collective and Visionaries. Tandem Health is an AI healthcare company founded in 2023 and headquartered in Sweden. Tandem Health operates as an AI partner within the healthcare sector across Europe, providing AI medical assistant support to clinicians in connection with patient visits.
September 15, 2026